Dexmedetomidine is a selective alpha 2 adrenergic agonist with known analgesic properties. Its perioperative use is associated with reduced pain scores and an opioid sparing effect. Management of postoperative pain in patients with a history of chronic opioid use can be challenging. Multimodal analgesia is recommended although the perioperative use of dexmedetomidine has not been extensively studied in this patient population. We present a case of intractable abdominal pain following open abdominoperineal resection in a patient with rectal cancer and a history of chronic opioid use. Following the introduction of dexmedetomidine into the patient's postoperative epidural solution, a noticeable decline in reported pain scores and use of breakthrough analgesia was appreciated. The analgesic efficacy of epidural dexmedetomidine in patients with a history of chronic opioid use warrants further study.
CITATION STYLE
Silvaggio, M. P., Toman, M. K., & Peters, B. (2020). Epidural dexmedetomidine infusion in a patient with chronic opioid use and intractable pain following abdominoperineal resection. Oxford Medical Case Reports, 2020(4), 1–4. https://doi.org/10.1093/omcr/omaa021
Mendeley helps you to discover research relevant for your work.